Hu J - Search Results

1

Competitive electroporation formulation for cell therapy.

Flanagan M, Gimble JM, Yu G, Wu X, Xia X, Hu J, Yao S, Li S. Flanagan M, et al. Among authors: hu j. Cancer Gene Ther. 2011 Aug;18(8):579-86. doi: 10.1038/cgt.2011.27. Epub 2011 Jun 10. Cancer Gene Ther. 2011. PMID: 21660061 Free PMC article.

2

The impact of non-electrical factors on electrical gene transfer.

Hu J, Cutrera J, Li S. Hu J, et al. Methods Mol Biol. 2014;1121:47-54. doi: 10.1007/978-1-4614-9632-8_3. Methods Mol Biol. 2014. PMID: 24510810 Free PMC article. Review.

3

Electroporation formulation for cell therapy.

Hu J, Li S. Hu J, et al. Methods Mol Biol. 2014;1121:55-60. doi: 10.1007/978-1-4614-9632-8_4. Methods Mol Biol. 2014. PMID: 24510811 Free PMC article.

4

CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors.

Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES, Li S. Hu J, et al. Mol Cancer. 2014 Feb 24;13:34. doi: 10.1186/1476-4598-13-34. Mol Cancer. 2014. PMID: 24565056 Free PMC article.

5

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells.

Noh H, Hu J, Wang X, Xia X, Satelli A, Li S. Noh H, et al. Among authors: hu j. Cell Commun Signal. 2015 Feb 27;13:14. doi: 10.1186/s12964-015-0093-y. Cell Commun Signal. 2015. PMID: 25889536 Free PMC article.

6

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li S. Yan J, et al. Among authors: hu j. J Natl Cancer Inst. 2015 May 13;107(8):djv137. doi: 10.1093/jnci/djv137. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 25971300 Free PMC article.

7

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells.

Satelli A, Hu J, Xia X, Li S. Satelli A, et al. Among authors: hu j. J Cancer. 2016 Aug 12;7(13):1824-1832. doi: 10.7150/jca.15622. eCollection 2016. J Cancer. 2016. PMID: 27698922 Free PMC article.

8

Regulation of NKG2D⁺CD8⁺ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.

Hu J, Batth IS, Xia X, Li S. Hu J, et al. Oncoimmunology. 2016 Nov 1;5(12):e1252012. doi: 10.1080/2162402X.2016.1252012. eCollection 2016. Oncoimmunology. 2016. PMID: 28123894 Free PMC article.

9

Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8⁺ T Cells and Histone Acetyltransferases.

Hu J, Bernatchez C, Zhang L, Xia X, Kleinerman ES, Hung MC, Hwu P, Li S. Hu J, et al. Cancer Immunol Res. 2017 Apr;5(4):300-311. doi: 10.1158/2326-6066.CIR-16-0234. Epub 2017 Feb 21. Cancer Immunol Res. 2017. PMID: 28223282 Free PMC article.

10

T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Hu J, Sun C, Bernatchez C, Xia X, Hwu P, Dotti G, Li S. Hu J, et al. Clin Cancer Res. 2018 Jun 15;24(12):2920-2934. doi: 10.1158/1078-0432.CCR-17-1365. Epub 2018 Feb 1. Clin Cancer Res. 2018. PMID: 29391351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,977 results

Search Page

Filters